RAVN missed badly (shrinking) and guided for more shrinkage in Q2 before a H2 acceleration. I love this company long-term, but it was expensive. My target is 38 a year out. 30-31 is the right price most likely. I will report back later if I have anything to add after hearing the call.
Each of the company's three divisions posted sales declines compared with a year ago, reflecting the current sluggish growth environment and tough year-over-year comparisons versus last year's record first quarter.
Comments